Conference Proceedings

Cemiplimab, a human monoclonal PD-1 Antibody, in Patients with advanced cutaneous Squamous Cell Carcinoma (adcSCC): Clinical Experience from Phase-1 and Phase-2 Studies

M Migden, A Guminski, K Lewis, N Khushalani, K Papadopoulos, Y Patel, M Andria, M Fury, D Rischin

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | WILEY | Published : 2019